NTRR Eyes Ancillary Market in Oregon, Alaska and D.C. After Voters Pass Cannabis Measures

The cannabis-related ancillary markets in two states and Washington, D.C. are wide open for products and services from Neutra Corp. (OTCBB:NTRR) and its partners after midterm voters passed measures to legalize the nutraceutical plant.

“We’re not surprised more states passed cannabis measures in the midterms. The mainstream tide is changing as more Americans assert their right to cannabis usage for wellness and recreation, and continue to make their voices heard at the polls,” said NTRR CEO Chris Brown. “We’re obviously thrilled the market for regulated cannabis has opened up even further and we’ll be looking for opportunities to fill the need for ancillary products and services from NTRR and our partners in Oregon, Alaska and Washington, D.C.”

Oregon and Alaska become the third and fourth states to legalize recreational cannabis, which means cannabis stores could open in both states as soon as 2016. Proposals also passed allowing the possession of cannabis in Washington, D.C. and South Portland, Maine, and Guam became the first U.S. territory to approve medical cannabis.

The rapid U.S. cannabis market expansion inspired NTRR to partner with up-and-coming innovators in a large ancillary market that is also benefiting from the fast-growing legalized cannabis industry. Alongside Vertigo Technologies, Diamond Anvil Designs and Surface to Air Solutions, the company is working to deliver powerful, practical breakthroughs in the indoor cultivation and delivery of cannabis and other nutraceuticals.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB:GWPRF), Terra Tech Corp. (OTCBB:TRTC) and ENDEXX Corp. (OTCBB:EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.